PremiumRatingsNutex Health Inc: Strong Financial Performance and Strategic Initiatives Justify Buy Rating Closing Bell Movers: PVH jumps 15% on earnings and guidance Nutex Health reports Q4 EPS $11.12 vs. ($7.47) last year PremiumThe FlyNutex Health price target raised to $50 from $45 at Maxim Nutex Health price target raised to $60 from $45 at Benchmark Nutex Health initiated with a Buy at Maxim PremiumThe FlyNutex Health announces 1-for-10 reverse stock split Nutex Health price target lowered to $5 from $6 at Benchmark Nutex Health Inc trading halted, news pending 
